6th International Conference on Mycology and Fungal Infections (PGR)

Event Information

Share this event

Date and Time

Location

Location

Venue will be informed to the Registered Participants

Madrid

Spain

View Map

Event description

Description

6th International Conference on Bacteriology and Infectious Diseases


About Conference
Fungal Infections 2019 welcomes attendees, presenters, and exhibitors from all over the world to Madrid, Spain. We are delighted to invite you all to attend and register for the “6th International Conference on Mycology and Fungal Infections” which is going to be held during October 07-08, 2019 at Madrid, Spain.

Fungal Infections 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.

At PULSUS Group, It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as Microbiologists, Mycologists, Cell Biologists, Bacteriologists, Biotechnologists, Researchers from academia & industry making the Fungal Infections conference a perfect platform.

The conference will be organized around the Theme ‘Impact of Mycology and Fungal Infections in addressing ultimate global health challenges’. Our goal is to deliver an outstanding program which covers the entire spectrum of Research & Innovations and Impact in Mycology and Fungal Infections and share the cross-cultural experiences of various treatment procedures.

Fungal Infections 2019 is an annual meeting of Mycology and Fungal Infections as well as committees to discuss the future of the antibiotics, vaccines, prevention of infection in terms of collaboration, structures and organizational development.

2018 Highlights

200+ Participation (70% Industry: 30% Academia)
9+ Keynote Speakers
30+ Plenary Speakers
3+ Exhibitors
14 Innovative Educational Sessions
B2B Meetings

Why to attend??

With members from around the world focused on learning about Microbes, Fungi, Bacteria, Infectious diseases, Anti-fungal Medicine and its advances; this is your best opportunity to reach the largest assemblage of participants from the Healthcare and research community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the Mycology and Fungal Infections treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in the health sector, Fungal Infection, pathogenic Fungi, genetically engineered Fungus, new therapies to treat Infection, vaccines, are hallmarks of this conference.


Target Audience

Mycologists
Healthcare Students, Scientists, and professors
Doctors
Biotechnologist
Microbiologist
Laboratorist
Genetic engineers
Bacteriology Researchers
Faculty of bacteriology and infectious diseases
Medical Colleges
Healthcare Associations and Societies
Business Entrepreneurs
Training Institutes

Conference Opportunities

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing
For Researchers and Faculty Members

For Universities, Associations & Societies

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group Registrations

For Business Delegates

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers

Exhibitor and Vendor Booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

------------------
Welcome Message
------------------
Fungal Infections 2019 welcomes attendees, presenters, and exhibitors from all over the world to Madrid, Spain. We are delighted to invite you all to attend and register for the “6th International Conference on Mycology and Fungal Infections” which is going to be held during October 07-08, 2019 at Madrid, Spain.

Fungal Infections 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.

At PULSUS Group, It is our ideology to bring maximum exposure to our attendees, so we make sure the event is a blend which covers professionals such as Microbiologists, Mycologists, Cell Biologists, Bacteriologists, Biotechnologists, Researchers from academia & industry making the Fungal Infections conference a perfect platform.

The conference will be organized around the Theme ‘Impact of Mycology and Fungal Infections in addressing ultimate global health challenges’. Our goal is to deliver an outstanding program which covers the entire spectrum of Research & Innovations and Impact in Mycology and Fungal Infections and share the cross-cultural experiences of various treatment procedures.

Fungal Infections 2019 is an annual meeting of Mycology and Fungal Infections as well as committees to discuss the future of the antibiotics, vaccines, prevention of infection in terms of collaboration, structures and organizational development.



Why Madrid?

Madrid is the capital city of Spain and lies on the River Manzanares. The city is inhabited by almost 3.2 million people with a metropolitan area population of approximately 6.5 million. Madrid is the third largest city in the European Union and it is the political, economical and cultural centre of the country. Madrid is one of the world's major global cities due to its economic output, high standard of living and market size. Madrid is the major financial centre of Southern Europe and organizes many fairs, the Cibeles Madrid Fashion Week being the notable one. Madrid is ranked as the 17th most liveable cities in the world. The historic neighborhoods and streets of Madrid allures many tourists across the globe. The city features many charismatic places like the Royal Palace of Madrid, the Buen Retiro Park, the Prado Museum, the Square Mayor and many more. Madrid is best known for its night life hosting live music shows by great artists who showcase music at its best. Madrid's bullfighting is world famous and is conducted during the festivities from March to end of October. Madrid is a beguiling place with whooping energy, trumpeting the world that no city on the earth is more alive than Madrid.


Sessions/Tracks

Session 01: Mycology and Mycosis

Mycology is the branch of biology concerned with the study of fungi, including their genetic and biochemical properties, their taxonomy and their use to humans as a source for tinder, medicine, food, and entheogens, as well as their dangers, such as toxicity or infection.

Mycosis is a fungal infection of animals, including humans. Mycoses are common and a variety of environmental and physiological conditions can contribute to the development of fungal diseases. Inhalation of fungal spores or localized colonization of the skin may initiate persistent infections; therefore, mycoses often start in the lungs or on the skin. Fungal infections of the skin was the 4th most common disease in 2010 affecting 984 million people. An estimation of 1.6 million people die each year of fungal infections.


Session 02: Fungal Infections and Diseases

These infections are commonly called 'ringworm', but are not caused by worms. They are superficial infections of the skin, hair or nails caused by a variety of fungi which otherwise live in the soil, on animals, or sometimes only on people. Infections are spread by direct skin contact (with humans or animals), or indirectly from contaminated articles on floors or in the soil. Shared changing rooms and showers are often a source of tinea, while some infections are spread by sharing of items such as towels. People shed tiny pieces of skin all the time and if these contain a small amount of the fungus, it is able to survive in the environment and cause infection in someone else.


Session 03: Medical Mycology or Fungal Infections

Fungal Infectious Diseases or Medical mycology is the study of mycoses and variety of physiological conditions and environmental are contributing to evolution of fungal diseases. In immune-compromised hosts systemic fungal infections are usually seen due to the inhalation or localization of fungal spores may persistent of systemic fungal infections lead to pulmonary infections. Fungal infections are usually seen on skin, nails, and hair. Common fungal infections are intertrigo, thrush, and pityriasis versicolor, athlete’s foot, nail infections, ring worm of the body, ring worm of the groin.


Session 04: Fungal genetics and Fungal Biology

Fungal Genetics and Biology, formerly known as Experimental Mycology, publishes experimental investigations of fungi and their traditional allies that relate structure and function to growth, reproduction, morphogenesis, and differentiation. This journal especially welcomes studies of gene organization and expression and of developmental processes at the cellular, subcellular, and molecular levels. The journal also includes suitable experimental inquiries into fungal cytology, biochemistry, physiology, genetics, and phylogeny.

Fungal Genetics and Biology publishes basic research conducted by mycologists, cell biologists, biochemists, geneticists, and molecular biologists.


Session 05: Diagnosis of fungal diseases

Early Diagnosis of fungal infection is critical to effective treatment. There are many impediments to diagnosis such as a diminishing number of clinical mycologists, cost, time to result, and requirements for sensitivity and specificity. In addition, fungal diagnostics must meet the contrasting needs presented by the increasing diversity of fungi found in association with the use of immunosuppressive agents in countries with high levels of medical care and the need for diagnostics in resource-limited countries where large numbers of opportunistic infections occur in patients with AIDS. Traditional approaches to diagnosis include direct microscopic examination of clinical samples, histopathology, culture, and serology. Emerging technologies include molecular diagnostics and antigen detection in clinical samples. Innovative new technologies that use molecular and immunoassay platforms have the potential to meet the needs of both resource-rich and resource-limited clinical environments.


Session 06: Pathogenic Fungi and Fungal Diseases

Pathogenic fungi cause disease in humans and in other organisms, which is called as fungal pathogenesis. Fungal pathogens can be divided into two general classes’ primary pathogens and opportunistic pathogens. Currently, there has been a dramatic increase in fungal infections of this type, in particular candidiasis, cryptococcosis, aspergillosis, and zygomycosis. More recently described mycoses of this category include hyalohyphomycosis and phaeohyphomycosis.

The superficial mycoses -these are superficial cosmetic fungal infections of the skin or hair shaft. Dermatophytosis - ringworm or tinea - ringworm of scalp, glabrous skin, and nails caused by a closely related group of fungi known as dermatophytes. The subcutaneous mycoses - these are chronic, localized infections of the skin and subcutaneous tissue following the traumatic implantation of the aetiologic agent. Infectious disease mycology - these are fungal infections of the body caused by dimorphic fungal pathogens.


Session 07: Applied Mycology in Horticulture and Agriculture

When the growth season has started and your cultivated plants are large enough for the mulching (green manuring) process to begin, you start adding the nettle substrate with the mycorrhizae spores to your cultivated area. First, apply the mulching material (whether lawn cuttings or other grasses) to the plant rows and, in humid weather, add to the rows some wide sprays of your microbiological inoculum. Before spreading your substrate, make sure to add to it cold water (as cold as you can get) for some 5 to 10 seconds, and then increase the temperature quickly to about 20oC. This is to activate the sporulation process, that is, to see to it that the mycorrhizae spores start to grow hyphae that will subsequently hook on to your cultivated plant roots.


Session 08: Mushroom for Health Immune System and Cancer

Edible mushrooms are the fleshy fruit bodies of several species of macro-fungi. They can appear either below ground or above ground where they may be picked by hand. Edibility may be defined by criteria that include the absence of poisonous effects on humans and desirable taste and aroma. Mushrooms play extremely important roles in the ecosystem, and some are famously delicious. Some are also famously deadly. In recent years has focused on various immunological and anti-cancer properties of certain mushrooms, they also offer other potentially important health benefits, including antioxidants, anti-hypertensive and cholesterol-lowering properties, liver protection, as well as anti-inflammatory, anti-diabetic, anti-viral and anti-microbial properties. These properties have attracted the interest of many pharmaceutical companies, which are viewing the medicinal mushroom as a rich source of innovative biomedical molecules. Mushrooms contain disease-busting polysaccharides, glycoproteins, ergosterols, triterpenoids, and immune-boosting chemicals. They can also be used to bolster a declining immune system during aging.


Session 09: Fungal Ecology

Fungi occur in all type of environment on earth and plays vital roles in most ecosystems. These are the major decomposers along with bacteria in most terrestrial and some aquatic ecosystems, and therefore play a critical role in biogeochemical cycles and in many food webs play an essential role in nutrient cycling by degrading organic matters to inorganic molecules, which can then re-enter to different anabolic metabolic pathways in plants and other organisms.


Session 10: Pharmaceutical Mycology

Mycology is the branch of biology concerned with the study of fungi, including their biochemical properties and genetic characteristic and their use to humans as a source medicine, food, and entheogens, as well as their dangers, such as poisoning or infection. Many fungi produce antibiotics, toxins and other secondary metabolites. Fungi have recently helped to produce other important drugs. cyclosporin, an anti-rejection substance that has helped in the development of organ-transplant surgery over the last few years.


Session 11: Opportunistic Fungal Infections

Opportunistic fungi refers to those fungi that normally would not cause infections in otherwise healthy people but are able to cause infection under certain circumstances such as immune defficiency, cancer, organ transplant, neutropenic patients, diabetes, debilitated patients and patients on long term antibiotics. Many fungi are opportunists and are usually not pathogenic except in an immunocompromised host. Causes of immunocompromise include AIDS, azotemia, diabetes mellitus, lymphoma, leukemia, other hematologic cancers, burns, and therapy with corticosteroids, immunosuppressants, or antimetabolites. Patients who spend more than several days in an ICU can become compromised because of medical procedures, underlying disorders, and/or undernutrition.


Session 12: Fungal Biotechnology

Biotechnology offers the potential for brand spanking new industrial processes that need less energy and are supported renewable raw materials. Some of the foremost necessary organisms employed in biotechnology are fungi. Fungi are employed in several industrial processes, like the assembly of enzymes, vitamins, polysaccharides, polyhydric alcohols, pigments, lipids, and glycolipids. A number of these products are made commercially whereas others are probably valuable in biotechnology, additionally to the multiple reaction sequences of fermentations, fungi are very helpful in polishing off biotransformation processes. These are getting essential to the fine-chemical trade within the production of single-isomer intermediates. Deoxyribonucleic acid technology, which incorporates yeasts and different fungi as hosts, has markedly exaggerated markets for microorganism enzymes.


Session 13: Applied Food Mycology

The presence of fungi in food has been both advantage and problems to food stores. Fungi can spoil large quantities of food and produce dangerous toxins that threaten human health; however, fungal spoilage in certain foods can produce a unique, highly prized food source and there are some very effective fungal derived medicines. A thorough understanding of the vast body of knowledge relating to food mycology requires an inclusive volume that covers both the beneficial and detrimental roles of fungi in our food supply. These include food groups such as bakery products, dairy products, beverages (e.g. fruit juices), dried fruits and nuts, and confectionary. Fungi can also present health risks by the production of specific toxic agents called mycotoxins, which are often poorly understood, but are being increasingly recognised as agents of both acute and chronic toxicity in humans and animals. This creates an opportunity in research towards the fungi and yeasts, and the problems they can cause in foods, in terms of spoilage and health effects. It will present a balanced view of the importance of these agents in the context of the modern food industry.


Session 14: Tinder Fungus

Tinder fungus grows on trees throughout the temperate and boreal regions of the northern hemisphere, and is found in Europe, northern Asia and in North America. In the north of its range it occurs mostly on birch trees (Betula spp.), but in parts of Europe it is widespread on beech trees (Fagus sylvatica) and also grows on sycamore (Acer pseudoplatanus) and aspen (Populus tremula). In North America it is most common on birches, but also occurs on maples (Acer spp.), poplars (Populus spp.) and alders (Alnus spp.). It has been recorded from Pakistan, northern Iran and Turkey, where it grows on poplars (Populus spp.), while in northern Japan it grows on Japanese beech trees (Fagus crenata). Tinder fungus has also been found on the island of Dominica in the Caribbean.


Session 15: Application of Mycorrhizal Technology

Mycorrhizal technology can profitably be applied in different forest areas for better nutrient utilization and more effective land use. Soils in Bangladesh forest either poor in P and other essential nutrients or have an immobile form of P similar to other tropical soils. In such condition, mycorrhizal fungi can play an important role in improving the plant growth by increasing the supply to roots with mineral nutrients in the soil . The application of mycorrhizal fungi will be suitable for inoculating the plants in a limited area with small amount of inoculum of the fungi. In this system, the external hyphal network of mycorrhizal fungi plays an important role in nutrient uptake, especially for those ions that are not very mobile in soil solution.


Session 16: Mycology Diversity

Fungi are organisms that assemble in complicated and dynamic communities. For the foremost half, fungi grow as a network of skinny filaments on the substrates like soil, wood, insect guts, living plant components, etc. which makes troublesome to find. Some species are refined in vitro; but the overwhelming majority isn't amenable to culturing, typically deed mycologists with very little to figure with through an experiment. Historically, taxonomists are answerable for enterprise the task of uncovering new fungi. Describing new species conjointly need the deposition of voucher specimens in official collections. The last decade witnessed a considerable increase in studies centered on fungal community ecology. Conducting fungal surveys may be a tedious semi-permanent undertaking and for an extended time Mycologists relied on the fruit body occurrence or culturing of fungal isolates to document species incidence and site-specific fungal selection.


Session 17: Fungal Skin Infections

Fungal skin infections are caused when fungal spores invade dead keratin cells in the body. The infections are highly contagious and can be transmitted from person to person very easily, but they can also be found in communal spaces. Fungus breeds well in damp, warm conditions, so places like leisure centres, swimming pools, children’s soft play areas and shared bathrooms can be full of fungus if they are not cleaned properly. Some of the most frequently occurring fungal skin infections include ringworm, intertrigo, athlete’s foot and tinea capitis. Though the symptoms of these infections can be unpleasant and irritating, they’re rarely dangerous, and can be treated easily with the appropriate topical cream or oral medications.


Session 18: Applied Mycology and Biotechnology

Most industrial processes used fungal cells for the bulk manufacturing of organic acids, proteins, enzymes, secondary metabolites and active pharmaceutical ingredients in white and red biotechnology. A number of challenges now need to be addressed to improve our strategies to control fungal pathogenicity and to optimise the use of fungi as sources for novel compounds. In addition to the multiple reaction sequences of fermentations, fungi are extremely useful in carrying out biotransformation processes. Molecular manipulations have been added to mutational techniques as a means of increasing yields of microbial processes and in the discovery of new drugs.

Session 19: Fungal Interactions

Bacterial and fungal interactions can form a range of physical associations that depend on various modes of molecular communication for their development and functioning. The combination of physical associations and molecular interactions between fungi and other microbes can result in a variety of different outcomes for each partner. In turn, these changes may affect the influence of the fungal-microbe complex. Applications are found in various biological fields i.e. Food processing, fermentation and brewing, cheese ripening, bioremediation of pollutants, natural product discovery and synthetic biology.


Session 20: Industrial Mycology

Filamentous fungi are used by industry for manufacture of a large variety of useful products. The products include metabolites, enzymes and food. Fungal cells can grow at different environmental conditions and environmental diversity. The chemical and physical conditions used for fungal propagation which depends up on fungal genetics and biology will have a great impact on the capability of these cells to accumulate the desired product(s). Mevinolin, cyclosporine A, β-lactam antibiotics, pneumocandins, ergotamine, strobilurins, and mycophenolic acid are examples of revolutionary pharmaceuticals and agrochemicals that have a fungal origin in spite of the success of bioactive fungal metabolites as pharmaceuticals and agrochemicals and fungi remain s an essentially untapped source of medicines because only a small fraction of the vast fungal kingdom has been explored for bioactive metabolite production. However, recent advances in the genetics of microbial secondary metabolite biosynthesis, genomics, and metabolic engineering will play an ever-increasing role in facilitating fungal bioactive metabolites discovery.


Session 21: Antifungal Therapeutics

The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. Additionally, identifying novel drug targets is challenging because there are many similarities between fungal and human cells. The most common antifungal targets include fungal RNA synthesis and cell wall and membrane components, though new antifungal targets are being investigated. Nonetheless, fungi have developed resistance mechanisms, such as overexpression of efflux pump proteins and biofilm formation, emphasizing the importance of understanding these mechanisms.

To address these problems, different approaches to preventing and treating fungal diseases are described in this review, with a focus on the resistance mechanisms of fungi, with the goal of developing efficient strategies to overcoming and preventing resistance as well as new advances in antifungal therapy. Due to the limited antifungal arsenal, researchers have sought to improve treatment via different approaches, and the synergistic effect obtained by the combination of antifungals contributes to reducing toxicity and could be an alternative for treatment.


Session 22: New and emerging treatments for fungal infections

Yeast infection treatments, which fail to respond to conventional anti-fungal drug treatments, have become increasingly reported, just like antibiotic resistant bacterial infections have over the years. There are many people who just don’t seem to respond to the azole class of drugs anymore, such as Fluconazole. This is partly due to the widespread, long-term use of azoles for treating and preventing yeast related health issues. Recent studies have show that exposure to azole treatment decreases the antifungal activity of amphotericin B. Two other types of antifungal drugs have also been shown to be active against azole-resistant candida yeast infections, they are Voriconazole (Vfend) which showed enhanced activity against fluconazole-resistant candidiasis and another drug called caspofungin (Cancidas) which has also shown activity against azole-resistant strains of candidiasis. No doubt there will be side effects associated with these antifungals as well.


Session 23: Business Visionary Investments Meet

The most important key factor in successful entrepreneurship is self-knowledge. 6th International Conference on Mycology and Fungal Infections aims to convey together all existing and budding bio entrepreneurs to share experiences and present new innovations and challenges in microbiological community. Every year, over a million companies are started in the world with about 5–10 of them classified as high technology companies.Turning ideas into business ventures is tricky and the opportunity-recognition step is critical in new venture creation. This gestalt in the entrepreneur's perception of the relationship between the invention and final product is refined into a business model that describes how the venture will make money or provide an appropriate return to the potential investors. Biological science is complex and rapidly changing and requires a specialized knowledge to understand the value of the innovation and its competitive position in the industry.


Session 24: Emerging Fungal Diseases of Human, Animals. and Plants

The fungi that are responsible for causing diseases in humans, animals and plants are referred to as Pathogenic fungi. Many of pathogenic fungi are naked in nature although they are eukaryotic. Candida species, Aspergillus species, Cryptococcus species, Histoplasma species are pathogenic in nature.Fungal diseases have contributed to death and disability in humans, triggered global wildlife extinctions and population declines, devastated agricultural crops, and altered forest ecosystem dynamics.

The past two decades have seen an increasing number of virulent infectious diseases in natural populations and managed landscapes. In both animals and plants, an unprecedented number of fungal and fungal-like diseases have recently caused some of the most severe die-offs and extinctions ever witnessed in wild species, and are jeopardizing food security. Human activity is intensifying fungal disease dispersal by modifying natural environments and thus creating new opportunities for evolution. We argue that nascent fungal infections will cause increasing attrition of biodiversity, with wider implications for human and ecosystem health, unless steps are taken to tighten biosecurity worldwide.


Market Analysis

Summary: Fungal Infections 2019 welcomes attendees, presenters, and exhibitors from all over the world to Madrid, Spain. We are delighted to invite you all to attend and register for the “6th International Conference on Mycology and Fungal Infections” which is going to be held during October 07-08, 2019 at Madrid, Spain. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Fungal Infections 2019, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Fungal Infections 2019 organizing committee look forward to Meet you at Madrid, Spain.

In the new Bio-economy, fungi play a very important role in addressing major global challenges, being instrumental for improved resource efficiency, making renewable substitutes for products from fossil resources, upgrading waste streams to valuable food and feed ingredients, counteracting life-style diseases and antibiotic resistance through strengthening the gut biota, making crop plants more robust to survive climate change conditions, and functioning as host organisms for production of new biological drugs.

This range of new uses of fungi all stand on the shoulders of the efforts of mycologists over generations: the scientific discipline mycology has built comprehensive understanding within fungal biodiversity, classification, evolution, genetics, physiology, ecology, pathogenesis, and nutrition. Applied mycology could not make progress without this platform. To unfold the full potentials of what fungi can do for both environment and man we need to strengthen the field of mycology on a global scale.

The global market for human antifungal therapeutics reached nearly $11.6 billion in 2012 and $11.8 billion in 2013. This market is expected to grow to nearly $13.9 billion in 2018 with a compound annual growth rate (CAGR) of 3.2% over the five-year period from 2013 to 2018. Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.

Industry Insights

The global antifungal drugs market size was valued at USD 10.7 billion in 2015 and is expected to witness growth due to the rising incidence of fungal infections including as per gillosis and candidiasis. These infections may lead to death in patients with a compromised immune system, such as in individuals afflicted with acquired immune deficiency syndrome and leukaemia and are hence termed as opportunistic infections. The increasing prevalence of infectious diseases and hospital-acquired infections is expected to fuel the demand for therapeutics over the forecast period.

Fungal infection is found to attack both superficial and systemic parts of the body, in the skin, eye, mouth, and vagina, leading to diseases, such as athlete's foot, fungal meningitis, and ringworm, which are treated using antifungal products. A wide range of fungicidal preparations such as creams, sprays, tablets, and injections, are available and increasing adoption of these products is predicted to drive the demand over the next seven years.



Market analysis for Global Infections :

Global marketplace record of infectious diseases focuses on the current trends within the infectious sicknesses therapeutic and diagnostic market, industry increase drivers, superior treatment options and restraints. It provides marketplace projections for the approaching years. It consists of evaluation of recent trends in generation for infection prognosis and treatment. The Global Infectious Disease Diagnostics Market is predicted to exceed extra than US$ 21.00 Billion via 2022 at a CAGR of 10% inside the given forecast period. The worldwide market for infectious disease diagnostic, vaccine, and remedy products reached $108.4 billion in 2015. And the reach of $126.2 billion in 2016 and $183.2 billion in 2021, demonstrating a compound annual increase rate (CAGR) of 7.7% from 2016 to 2021.And the global marketplace for top 6 infectious ailment is expected to reach USD 86.2 billion by way of 2025, in step with a new file with the aid of Grand View Research, Inc.

The marketplace is usually pushed via growing quantity of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis instances globally. Government and private agencies are making an investment closely inside the healthcare area to prevent, diagnose, and deal with infectious diseases; growing investments for improvement of new tablets to treat infectious sicknesses, and increasing quantity of initiatives for growing cognizance about those conditions are anticipated to reinforce the market at some stage in the forecast length. Furthermore, growing quantity of patent expirations and access of ordinary tablets within the marketplace are expected to growth the call for infectious disease therapeutics due to their low costs. In addition, availability of compensation for prognosis & treatment of those infections and unfastened distribution of medication via manufacturers in areas with high incidence of those sicknesses are factors further anticipated to propel the marketplace boom. However, low penetration charge of anti-infective and availability of huge wide variety of counterfeit drugs are anticipated to restraint the marketplace boom for the duration of the forecast length. Some of the key contributors are Novartis AG, Gilead, GlaxoSmithKline %, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., Bio Cryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH

Infections related Associations worldwide:

Association for Professionals in Infection Control and Epidemiology
Centers for Disease Control and Prevention
Infectious Diseases Society of America
National Institute of Allergy and Infectious Diseases
World Health Organization
National Institute of Allergy and Infectious Diseases
Centers for Disease Control and Prevention
Directors of Health Promotion and Education
National Foundation for Infectious Diseases
National Institute of Allergy and Infectious Diseases

Top Hospitals across Global:

Nuffield Health Bristol Hospital – The Chesterfield – Bristol, U.K.
Upper River Valley Hospital – New Brunswick, Canada
Hackensack University Medical Centre – Hackensack, New Jersey
Legacy Salmon Creek Medical Centre – Portland, Washington
Wooridul Spine Hospital – Seoul, South Korea
Houston Methodist Hospital – Houston, Texas
Hartford Hospital – Hartford, Connecticut
University of Pittsburgh Medical Centre – Pittsburgh, Pennsylvania
University of Texas MD Anderson Cancer Centre – Houston, Texas
UCLA Health: Ronald Reagan UCLA Medical Centre – Los Angeles, California
Mercy San Juan Medical Centre – Carmichael, California
Massachusetts General Hospital – Boston, Massachusetts
Ramkhamhaengs Hospital – Bangkok, Thailand

Major Universities on Infectious & Microbiology:

National University of Singapore
Nanyang Technological University
PSB Academy
Management Development Institute of Singapore
Nanyang Polytechnic
Singapore University of Technology and Design
Singapore Polytechnic
Ngee Ann Polytechnic
Republic Polytechnic

Pharma companies:

Beacons Pharmaceuticals Pte Ltd
iNova Pharmaceuticals (Singapore)
Sanofi - Aventis
Vifor Pharma
Astrazeneca Singapore Pte Ltd
CCM Pharmaceuticals (S) Pte Ltd
Aventis Pharma
Servier (s) Pte Ltd
Hyphens Pharma Pte. Ltd.
Pfizer


Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
PULSUS- NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

VIO190116CRE

Share with friends

Date and Time

Location

Venue will be informed to the Registered Participants

Madrid

Spain

View Map

Save This Event

Event Saved